about
Iron metabolism and the innate immune response to infectionImmunology for the toxicologic pathologistAn Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to PathologyATP binding by NLRP7 is required for inflammasome activation in response to bacterial lipopeptidesThe PYRIN Domain-only Protein POP1 Inhibits Inflammasome Assembly and Ameliorates Inflammatory DiseaseMeasuring NLR Oligomerization I: Size Exclusion Chromatography, Co-immunoprecipitation, and Cross-LinkingA high-fat diet impairs reproduction by decreasing the IL1β level in mice treated at immature stage.The PYRIN domain-only protein POP2 inhibits inflammasome priming and activation.Shigella IpaH7.8 E3 ubiquitin ligase targets glomulin and activates inflammasomes to demolish macrophages.Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophagesIL-1β processing in mechanical ventilation-induced inflammation is dependent on neutrophil factors rather than caspase-1Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses.Glucocorticoids Mediate Short-Term High-Fat Diet Induction of Neuroinflammatory Priming, the NLRP3 Inflammasome, and the Danger Signal HMGB1Cell death and infection: a double-edged sword for host and pathogen survival.High-fat diet and aging interact to produce neuroinflammation and impair hippocampal- and amygdalar-dependent memory.Helicobacter pylori induces IL-1β and IL-18 production in human monocytic cell line through activation of NLRP3 inflammasome via ROS signaling pathway.A Role for the Inflammasome in Spontaneous Labor at Term with Acute Histologic Chorioamnionitis.A Role for the Inflammasome in Spontaneous Labor at Term.COPs and POPs Patrol Inflammasome Activation.NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages.New Aspects in Immunopathology of Mycobacterium tuberculosis
P2860
Q26860448-F60E6AFB-68A4-4599-87B2-D8BD494CCA3DQ26992291-10C66062-04AA-423C-9940-D66A3B5D0E66Q27004333-E2BCE679-CA4C-41E7-A9A0-DE2544E09CCDQ28388318-BED41D4C-14E5-4A99-ADA3-C34E7BDDE657Q28395210-9A5091A7-BD58-4D2C-8200-BB27B70E7F96Q28822243-BD6E449B-9691-43D4-AA04-36E042B758CEQ33673768-C68BD0BB-7D7A-4053-9B58-9AD520E31508Q33780915-FE9ED414-BF49-498E-8079-175724D74FD3Q34407723-4B4849E7-5F6D-4F8E-AA83-920E505942C9Q34916951-60362C84-2C1D-4A04-9527-FACD58A7CEACQ35860827-8EF4DADB-C777-4A73-A024-6BC176BC44C7Q36702336-BFA8A940-D03B-42CD-A8FE-C1C553D17832Q36731284-16BDC5F9-DD6E-44E5-9FA6-27229C83D60AQ37215568-3479AB70-E94A-4191-B0B6-1E0C43499401Q37962256-27474E45-2C92-4865-933C-1117E79F2CE2Q38673653-D9E0EBA5-1093-484B-B0D1-277573DEC7F8Q38891763-D19E7351-BA3F-422C-B14A-F033814A45AAQ40079838-D6B9710F-76B4-428C-B147-D7096206BCF0Q40866852-937AA515-99A0-4B3F-88D0-7D8060F2F546Q47661727-695D4EC6-E398-43CA-A542-4AB3B97D0662Q52715020-499C6029-F159-42C4-88F9-35D749B74EE4Q52727771-CCE0C66D-4AD3-49ED-8B26-7CA5AAF4F2B8Q58905565-53283F45-9C09-4455-A047-C03EEA47F23C
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inflammasomes and their activation.
@ast
Inflammasomes and their activation.
@en
Inflammasomes and their activation.
@nl
type
label
Inflammasomes and their activation.
@ast
Inflammasomes and their activation.
@en
Inflammasomes and their activation.
@nl
prefLabel
Inflammasomes and their activation.
@ast
Inflammasomes and their activation.
@en
Inflammasomes and their activation.
@nl
P2093
P2860
P1476
Inflammasomes and their activation
@en
P2093
Andrea Dorfleutner
Christian Stehlik
P2860
P304
P356
10.1615/CRITREVIMMUNOL.V30.I5.50
P50
P577
2010-01-01T00:00:00Z